Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells

Cancer Biology and Therapy

Volumn 14, Issue 1, 2013, Pages 45-55

  Ou, Yunwei ^a,b   Ma, Liying ^a   Ma, Ling ^c   Huang, Zhen ^a   Zhou, Wei ^a   Zhao, Chunling ^a   Zhang, Bailin ^a   Song, Yongmei ^a   Yu, Chunjiang ^b   Zhan, Qimin ^a  

^a CANCER HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cisplatin; Cyclin B1; ESCC cells; Paclitaxel

Indexed keywords

CISPLATIN; CYCLIN B1; PACLITAXEL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL SURVIVAL; CELL THERAPY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SENSITIVITY; DRUG TARGETING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MITOCHONDRION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CHROMONES; CISPLATIN; CYCLIN B1; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MORPHOLINES; PACLITAXEL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84872149216     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.22627     Document Type: Article

References (49)

1. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349:2241-52; PMID:14657432; http://dx.doi.org/10.1056/NEJMra035010.
2. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55:10-30; PMID:15661684; http://dx.doi.org/10.3322/canjclin.55.1.10.
3. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, et al. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis 2008; 29:307-15; PMID:18048386; http://dx.doi.org/10.1093/carcin/bgm269.
4. Kim JY, Do YR, Park KU, Kim MK, Lee KH, Bae SH, et al. A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer. Cancer Chemother Pharmacol 2010; 66:31-6; PMID:19763571; http://dx.doi.org/10.1007/s00280-009-1130-6.
5. Kantari C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 2011; 1813:558-63; PMID:21295084; http://dx.doi.org/10.1016/j.bbamcr.2011.01.026.
6. Tsai WS, Yeow WS, Chua A, Reddy RM, Nguyen DM, Schrump DS, et al. Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. Mol Cancer Ther 2006; 5:2977-90; PMID:17172403; http://dx.doi.org/10. 1158/1535-7163.MCT-05-0514.
7. Borgne A, Versteege I, Mahé M, Studeny A, Léonce S, Naime I, et al. Analysis of cyclin B1 and CDK activity during apoptosis induced by camptothecin treatment. Oncogene 2006; 25:7361-72; PMID:16785996; http://dx.doi.org/10.1038/sj.onc.1209718.
8. Jun DY, Kim JS, Park HS, Song WS, Bae YS, Kim YH. Cytotoxicity of diacetoxyscirpenol is associated with apoptosis by activation of caspase-8 and interruption of cell cycle progression by down-regulation of cdk4 and cyclin B1 in human Jurkat T cells. Toxicol Appl Pharmacol 2007; 222:190-201; PMID:17559898; http://dx.doi.org/10.1016/j.taap.2007.04.011.
9. Tommasi S, Besaratinia A, Wilczynski SP, Pfeifer GP. Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy. Oncogene 2011; 30:690-700; PMID:20890300; http://dx.doi.org/10.1038/ onc.2010.440.
10. Chang E, Donahue J, Smith A, Hornick J, Rao JN, Wang JY, et al. Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. J Thorac Cardiovasc Surg 2010; 140:225-32; PMID:20236666; http://dx.doi.org/10.1016/j.jtcvs.2009.11. 038.
11. Lubin DJ, Butler JS, Loh SN. Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function. J Mol Biol 2010; 395:705-16; PMID:19913028; http://dx.doi.org/10.1016/j.jmb.2009.11.013.
12. Li K, He W, Lin N, Wang X, Fan QX. Downregulation of N-cadherin expression inhibits invasiveness, arrests cell cycle and induces cell apoptosis in esophageal squamous cell carcinoma. Cancer Invest 2010; 28:479-86; PMID:20014942; http://dx.doi.org/10.3109/07357900903476745.
13. Wang X, Dong L, Xie J, Tong T, Zhan Q. Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis. Cancer Biol Ther 2009; 8:1852-9; PMID:19770595; http://dx.doi.org/10.4161/cbt.8.19. 9550.
14. Jin P, Hardy S, Morgan DO. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 1998; 141:875-85; PMID:9585407; http://dx.doi.org/10.1083/jcb.141.4.875.
15. Tang L, Zhang Y, Pan H, Luo Q, Zhu XM, Dong MY, et al. Involvement of cyclin B1 in progesterone-mediated cell growth inhibition, G2/M cell cycle arrest, and apoptosis in human endometrial cell. Reprod Biol Endocrinol 2009; 7:144; PMID:19968870; http://dx.doi.org/10.1186/1477-7827-7-144.
16. Yuan J, Yan R, Krämer A, Eckerdt F, Roller M, Kaufmann M, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene 2004; 23:5843-52; PMID:15208674; http://dx.doi.org/10.1038/sj. onc.1207757.
17. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, et al. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res 2002; 62:6414-7; PMID:12438226.
18. Risinger JI, Hayes AK, Berchuck A, Barrett JC. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997; 57:4736-8; PMID:9354433.
19. Risinger JI, Hayes K, Maxwell GL, Carney ME, Dodge RK, Barrett JC, et al. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics. Clin Cancer Res 1998; 4:3005-10; PMID:9865913.
20. Marsh DJ, Dahia PL, Caron S, Kum JB, Frayling IM, Tomlinson IP, et al. Germline PTEN mutations in Cowden syndrome-like families. J Med Genet 1998; 35:881-5; PMID:9832031; http://dx.doi.org/10.1136/jmg.35.11.881.
21. Bellacosa A, Testa JR, Staal SP, Tsichlis PN. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991; 254:274-7; PMID:1833819; http://dx.doi.org/10.1126/science.1833819.
22. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, et al. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res 2000; 60:5988-94; PMID:11085518.
23. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 1998; 279:710-4; PMID:9445477; http://dx.doi.org/10.1126/science.279.5351.710.
24. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839.
25. McDonnell MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells. Cell Death Differ 2003; 10:1005-15; PMID:12934075; http://dx.doi.org/10.1038/sj.cdd.4401271.
26. Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol 1999; 17:2941-53; PMID:10561374.
27. Wan X, Helman LJ. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene 2003; 22:8205-11; PMID:14603261; http://dx.doi.org/10.1038/sj. onc.1206878.
28. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 1999; 96:4240-5; PMID:10200246; http://dx.doi.org/10.1073/ pnas.96.8.4240.
29. Chae HD, Broxmeyer HE. SIRT1 Deficiency Downregulates PTEN/JNK/FOXO1 Pathway to Block ROS-Induced Apoptosis in Mouse Embryonic Stem Cells. Stem Cells Dev 2011; 20:1277-85; PMID:21083429; http://dx.doi.org/10.1089/scd.2010.0465.
30. Li HF, Keeton A, Vitolo M, Maddox C, Rasmussen L, Hobrath J, et al. A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells. J Biomol Screen 2011; 16:383-93; PMID:21335596; http://dx.doi.org/10.1177/1087057110397357.
31. Yamada K, Kunishima N, Mayanagi K, Ohnishi T, Nishino T, Iwasaki H, et al. Crystal structure of the Holliday junction migration motor protein RuvB from Thermus thermophilus HB8. Proc Natl Acad Sci USA 2001; 98:1442-7; PMID:11171970; http://dx.doi.org/10.1073/pnas.98.4.1442.
32. Itoh N, Semba S, Ito M, Takeda H, Kawata S, Yamakawa M. Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma. Cancer 2002; 94:3127-34; PMID:12115344; http://dx.doi.org/10.1002/cncr.10591.
33. Xie XH, An HJ, Kang S, Hong S, Choi YP, Kim YT, et al. Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line. Int J Cancer 2005; 116:520-5; PMID:15818617; http://dx.doi.org/10.1002/ijc.21056.
34. Yuan J, Krämer A, Matthess Y, Yan R, Spänkuch B, Gätje R, et al. Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo. Oncogene 2006; 25:1753-62; PMID:16278675; http://dx.doi.org/10.1038/ sj.onc.1209202.
35. Gomez LA, de Las Pozas A, Reiner T, Burnstein K, Perez-Stable C. Increased expression of cyclin B1 sensitizes prostate cancer cells to apoptosis induced by chemotherapy. Mol Cancer Ther 2007; 6:1534-43; PMID:17513602; http://dx.doi.org/10.1158/1535-7163.MCT-06-0727.
36. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94:491-501; PMID:9727492; http://dx.doi.org/10.1016/S0092-8674(00)81590-1.
37. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, et al. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 1999; 144:281- 92; PMID:9922454; http://dx.doi.org/10.1083/jcb.144.2.281.
38. Kumar N. Taxol-induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 1981; 256:10435-41; PMID:6116707.
39. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277:665-7; PMID:423966; http://dx.doi.org/10.1038/ 277665a0.
40. Horwitz SB. Mechanism of action of taxol. Trends Pharmacol Sci 1992; 13:134-6; PMID:1350385; http://dx.doi.org/10.1016/0165-6147(92)90048-B.
41. Jordan MA, Wendell K, Gardiner S, Derry WB, Copp H, Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 1996; 56:816-25; PMID:8631019.
42. Szymkowski DE, Yarema K, Essigmann JM, Lippard SJ, Wood RD. An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts. Proc Natl Acad Sci USA 1992; 89:10772-6; PMID:1438274; http://dx.doi.org/10.1073/pnas.89.22.10772.
43. Akca H, Demiray A, Tokgun O, Yokota J. Invasiveness and anchorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/ NFkB pathway in lung cancer cells. Lung Cancer 2011; 73:302-9; PMID:21333374; http://dx.doi.org/10.1016/j.lungcan.2011.01.012.
44. Wang T, Lv JH, Zhang XF, Li CJ, Han X, Sun YJ. Tissue inhibitor of metalloproteinase-1 protects MCF-7 breast cancer cells from paclitaxel-induced apoptosis by decreasing the stability of cyclin B1. Int J Cancer 2010; 126:362-70; PMID:19609944; http://dx.doi.org/10.1002/ijc.24753.
45. Davies MA, Koul D, Dhesi H, Berman R, McDonnell TJ, McConkey D, et al. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res 1999; 59:2551-6; PMID:10363971.
46. Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK, et al. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 2004; 23:5853-7; PMID:15208673; http://dx.doi.org/10.1038/ sj.onc.1207721.
47. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275:1943-7; PMID:9072974; http://dx.doi.org/10. 1126/science.275.5308.1943.
48. Han Y, Wei F, Xu X, Cai Y, Chen B, Wang J, et al. Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19:455-7; PMID:12476413.
49. Miyahara T, Ueda K, Akaboshi M, Shimada Y, Imamura M, Utsumi H. Hyperthermic enhancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum(II) in cultured human esophageal cancer cells. Jpn J Cancer Res 1993; 84:336-40; PMID:8486532; http://dx.doi.org/10.1111/j.1349- 7006.1993.tb02875.x.